United States securities and exchange commission logo





                               July 5, 2022

       Jonas Grossman
       Chief Executive Officer
       Chardan NexTech Acquisition 2 Corp.
       17 State Street, 21st Floor
       New York, New York 10004

                                                        Re: Chardan NexTech
Acquisition 2 Corp.
                                                            Registration
Statement on Form S-4
                                                            Filed June 17, 2022
                                                            File No. 333-265713

       Dear Mr. Grossman:

              We have reviewed your registration statement and have the
following comments. In
       some of our comments, we may ask you to provide us with information so
we may better
       understand your disclosure.

              Please respond to this letter by amending your registration
statement and providing the
       requested information. If you do not believe our comments apply to your
facts and
       circumstances or do not believe an amendment is appropriate, please tell
us why in your
       response.

              After reviewing any amendment to your registration statement and
the information you
       provide in response to these comments, we may have additional comments.

       Form S-4 filed June 17, 2022

       General Risk Factors
       The uncertainty in global economic conditions, page 56

   1.                                                   You disclose that you
may be unable to offset material price inflation through increased
                                                        prices to customers.
Please update your disclosure to identify actions planned or taken, if
                                                        any, to mitigate
inflationary pressures.
       Fairness Opinion of Duff & Phelps, page 90

   2.                                                   We note your response
to our prior comment seven. You state that Duff & Phelps
                                                        delivered its opinion
to the Chardan Board "solely in their capacity as members of the
                                                        Chardan Board." This
appears to be a limitation on reliance by shareholders in
                                                        the fairness opinion.
Shareholders are entitled to rely upon all disclosure contained in the
 Jonas Grossman
FirstName   LastNameJonas  Grossman
Chardan NexTech    Acquisition 2 Corp.
Comapany
July 5, 2022NameChardan NexTech Acquisition 2 Corp.
July 5,2 2022 Page 2
Page
FirstName LastName
         registration statement/proxy, especially as it relates to the fairness
of the consideration to
         be paid. Please delete this limitation here and in Annex I.
U.S. Federal Income Tax Considerations, page 153

3.       Please revise the tax disclosure in your registration statement to:
(i) Remove language that
         "generally" certain tax consequences will apply and express a firm
opinion for each
         material tax consequence or explain why such an opinion cannot be
given; and (ii) state in
         your disclosure that the discussion is the opinion of tax counsel and
identify
         counsel. Also, we note your intention and expectation that the
transaction qualify as a
         reorganization within the meaning of Section 368(a) of the U.S.
Internal Revenue Code of
         1986, as amended. Please revise your disclosure to more clearly state
         counsel's tax opinion on whether the transaction will qualify as a
reorganization and
         include appropriate risk factor disclosure. In addition, please also
file a tax opinion as an
         exhibit to the filing. Refer to Item 601(b)(8) of Regulation S-K, per
Item 21(a) of Form S-
         4, and, for guidance, Section III of Staff Legal Bulletin No. 19.
Chardan's Management's Discussion and Analysis of Financial Condition and
Results of
Operations
Recent Developments, page 169

4.       We note your response to prior comment 10; however, we continue to
note an
         inconsistency in your disclosures. Although you now disclose here that
ASU 2020-06 is
         effective for you on January 1, 2024 and you are currently assessing
the impact of
         adoption, you disclose in the notes to your financial statements on
page F-15 that ASU
         2020-06 is effective for you on January 1, 2024 and you early adopted
on January 1,
         2021. Please correct or reconcile these disclosures.
Certain Projected Financial Information Of Dragonfly, page 202

5.       We note your response to our prior comment 11. Where possible, please
quantify the
         material estimates and assumptions used to prepare the Dragonfly
Projected Financial
         Information. Please also expand your disclosure to discuss how these
projections relate to
         Dragonfly's historical financial results.
Unaudited Pro Forma Condensed Combined Financial Information, page 206

6.       We note the Earnout Shares are expected to be recognized at fair value
upon the closing of
         the Business Combination and classified in stockholders    equity. We
also note the
         preliminary fair value of the Earnout Shares is $288.8 million. Based
on the terms of the
         Earnout Shares, please more fully explain how you determined the
accounting treatment
         for these shares and how you determined equity classification is
appropriate. Please also
         disclose and more fully explain how you determined the preliminary
fair value of the
         Earnout Shares, including the material assumptions.
7.       We note the new shares of common stock that will be issued to
Dragonfly Equity Holders
 Jonas Grossman
FirstName   LastNameJonas  Grossman
Chardan NexTech    Acquisition 2 Corp.
Comapany
July 5, 2022NameChardan NexTech Acquisition 2 Corp.
July 5,3 2022 Page 3
Page
FirstName LastName
         will be allocated between the holders of Dragonfly common stock and
options to acquire
         Dragonfly common stock, after the conversion of Dragonfly preferred
stock into
         Dragonfly common stock. Please more fully disclose the conversion
terms of the preferred
         stock. We also note disclosures in the forepart of the filing that all
Dragonfly options will
         be converted into New Dragonfly options and that the portion of the
Aggregate Merger
         Consideration reflecting the conversion of the Dragonfly options is
calculated assuming
         all New Dragonfly options are net-settled but Dragonfly options may,
by their terms, be
         cash-settled resulting in additional dilution. Please more fully
explain the accounting for
         options, including the exchange of Dragonfly options for New Dragonfly
options in the
         pro forma financial statements. Please also more fully explain the
terms of Dragonfly
         options that could result in cash-settlement and explain how the
potential cash settlement
         was considered in determining the appropriate accounting for options
in Dragonfly   s
         historical financial statements.
Dragonfly Related Party Transactions, page 251

8.       You disclose Dragonfly's loan to its Chief Financial Officer, Mr.
Marchetti. Please tell us
         on how you intend to comply with Section 13(k) of the Securities
Exchange Act of 1934
         with respect to the loan Dragonfly has made to Mr. Marchetti.
Interim Financial Statements - Chardan
Condensed Balance Sheets, page F-22

9.       Please correct the number of common shares at redemption value that
are outstanding as
         of December 31, 2021 disclosed under redeemable common stock and
stockholders
         equity (deficit).
General

10.      With a view toward disclosure, please tell us whether your sponsor is,
is controlled by, or
         has substantial ties with a non-U.S. person. Please also tell us
whether anyone or any
         entity associated with or otherwise involved in the transaction, is,
is controlled by, or has
         substantial ties with a non-U.S. person. If so, also include risk
factor disclosure that
         addresses how this fact could impact your ability to complete your
initial business
         combination. For instance, discuss the risk to investors that you may
not be able to
         complete an initial business combination with a U.S. target company
should the
         transaction be subject to review by a U.S. government entity, such as
the Committee on
         Foreign Investment in the United States (CFIUS), or ultimately
prohibited. Further,
         disclose that the time necessary for government review of the
transaction or a decision to
         prohibit the transaction could prevent you from completing an initial
business
         combination and require you to liquidate. Disclose the consequences of
liquidation to
         investors, such as the losses of the investment opportunity in a
target company, any price
         appreciation in the combined company, and the warrants, which would
expire worthless.

         We remind you that the company and its management are responsible for
the accuracy
 Jonas Grossman
Chardan NexTech Acquisition 2 Corp.
July 5, 2022
Page 4

and adequacy of their disclosures, notwithstanding any review, comments, action
or absence of
action by the staff.

       Refer to Rules 460 and 461 regarding requests for acceleration. Please
allow adequate
time for us to review any amendment prior to the requested effective date of
the registration
statement.

        You may contact Heather Clark, Staff Accountant, at (202) 551-3624 or
Anne
McConnell, Staff Accountant, at (202) 551-3709 if you have questions regarding
comments on
the financial statements and related matters. Please contact Bradley Ecker,
Staff Attorney, at
(202) 551-4985 or Sherry Haywood, Staff Attorney, at (202) 551-3345 with any
other questions.



FirstName LastNameJonas Grossman                           Sincerely,
Comapany NameChardan NexTech Acquisition 2 Corp.
                                                           Division of
Corporation Finance
July 5, 2022 Page 4                                        Office of
Manufacturing
FirstName LastName